Study Details
Erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma
Clinicaltrials.gov ID
Astellas Study ID
OSI-774-205
EudraCT ID
2009-016836-11
Condition
Ependymoma
Phase
Phase 2
Age
1 years - 21 years
Sex
Female & Male
Product
N/A
Type
Interventional
Trial Dates
Sep 2010 - Nov 2012
Masking
None (Open Label)
Enrollment number
25
A Randomized, Phase 2 Study of Single-agent Erlotinib versus Oral Etoposide in Patients with Recurrent or Refractory Pediatric Ependymoma
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for Erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Steven D Hassenfeld Children’s Center – New York University
New York, United States, 10016
University of Wisconsin Pediatric Hematology/Oncology Department
Madison, United States, 53705-2275
Stanford University and Lucile Packard Children’s Hospital
Palo Alto, United States, 94304
Royal Manchester Children's Hospital Ward 84
Manchester, United Kingdom, M13 9W2
Birmingham Children's Hospital
Birmingham, United Kingdom, B4 6NH
Royal Marsden Hospital
Sutton, United Kingdom, SM2 5PT
Children's Medical Center, Dallas Center for Cancer and Blood Disorders
Dallas, United States, 75235
University of Alabama at Birmingham Dept. of Pediatric-Hematology/Oncology
Birmingham, United States, 35233
Children’s and Women’s Health Center of BC Division of Hematology/ Oncology/ BMT
Vancouver, Canada, V6H 3V4
University of Florida Shands Children's Hospital
Gainesville, United States, 32610-0296
Strollery Children's Hospital Division of Hematology/Oncology
Edmonton, Canada, T6G 2B7
Paediatric Oncology and Haematology Offices
Leeds, United Kingdom, LS1 3EX
Penn State Hershey Children's Hospital
Hershey, United States, 17110
Children's Memorial Medical Hospital
Chicago, United States, 60614
University of Miami
Miami, United States, 33136
Royal Hospital for Sick Children
Glasgow, United Kingdom, G3 8SJ
Oregon Health & Sciences University Doembecher Children's Hospital
Portland, United States, 97124
Center for Cancer and Blood Disorders-Phoenix Children's Hospital
Phoenix, United States, 85016
Hospital for Sick Children
Toronto, Canada, M5G 1X8
Alder Hey Children’s NHS Foundation Trust Department of Oncology
Liverpool, United Kingdom, L12 1AP
Amplatz Children's Hospital University of Minnesota Medical Center- Pediatric Hematology Oncology
Minneapolis, United States, 55455
University of Nottingham Children's Brain Tumour Research Centre
Nottingham, United Kingdom, NG7 2UH
Children's National Medical Center - D.C. Center for Cancer and Blood Disorders
Washington, United States, 20010
Emory University Children's Healthcare of Atlanta Aflac Cancer Center & Blood Disorders
Atlanta, United States, 30322
Children's Hospital of Orange County (CHOC)
Orange, United States, 92868
Columbia University Children's Hospital of New York Presbyterian Child & Adolescent Oncology Center
New York, United States, 10032
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, United States, 15224
Dana-Farber Cancer Institute Department of Pediatric Neuro-oncology
Boston, United States, 02115
Johns Hopkins University School of Medicine
Baltimore, United States, 21287
Children's Hospital Center for Cancer and Blood Disorders
Aurora, United States, 80045